How we work
BioGntx invites partners to improve their products
Partnerships developement in 4 steps:
References
[1] Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70-81. doi:10.1016/S0140-6736(17)31796-8 – https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31796-8/fulltext
[2] Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-836.e2. doi:10.1016/j.cgh.2017.06.037 – https://www.cghjournal.org/article/S1542-3565(17)31352-X/fulltext
[3] Cellier C, Delabesse E, Helmer C, Patey-Mariaud De Serre N, Jabri B, Macintyre E, Cerf-Bensussan N, Brousse N, Colombel JF. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356(9225):203-208. doi:10.1016/S0140-6736(00)02472-4 – https://www.ncbi.nlm.nih.gov/pubmed/10963196
[4] Jabri B, Sollid LM. Mechanisms of Disease: Immunopathogenesis of Celiac Disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3(9):516-525. doi:10.1038/ncpgasthep0608 – https://www.nature.com/articles/ncpgasthep0608
[5] (Source: Genetics Home Reference, a resource from the U.S. National Library of Medicine – https://ghr.nlm.nih.gov/condition/noonan-syndrome#statistics)
[6] (Source: National Organization for Rare Disorders – https://rarediseases.org/rare-diseases/noonan-syndrome/)
[7] (Source: Genetics Home Reference – https://ghr.nlm.nih.gov/condition/noonan-syndrome)
[8] Tekst: Expand-patientorganisation
